Abstract: A diabetic foot management system according to one aspect includes a diabetic foot monitoring apparatus configured to measure user's foot condition information; and a diabetic foot analysis apparatus configured to determine a degree of progression of user's diabetic foot ulcer from the measured foot condition information using a machine learning-based diabetic foot determination model.

Abstract: Disclosed are a tissue expander for breast reconstruction comprising an MMP sensor and thus being capable of real-time capsular contracture monitoring and treatment, and a patient information system linked thereto. According to these, a patient or medical staff can easily check and evaluate capsular contracture, which may occur when wearing a tissue expander for breast reconstruction, and whether inflammation, a side effect, or the like is caused thereby, even outside the human body in real time. Accordingly, before or when capsular contracture occurs, effective treatment and response are possible.

Abstract: Disclosed are an artificial prosthesis and a method for manufacturing same. The artificial prosthesis includes a surface having a pattern formed thereon, the pattern comprising straight line shapes aligned in parallel with each other, and has the effect of reducing inflammation in a region implanted with the prosthesis, and effectively reducing capsular contracture side effects.

Abstract: The present invention relates to: a composition for wound healing, containing a metal-organic framework (MOF)as an active ingredient; and a wound dressing material comprising a hydrophilic superabsorbent polymer and the MOF, and the composition and the wound dressing material have a wound healing ability, specifically, the excellent effect of healing a wound by promoting fibroblast movement, do not significantly differ from a control group with respect to cytotoxicity, thereby exhibiting excellent safety when applied to a wound site, and have the excellent effect of having a wound recovery rate high enough to be checked with the naked eye over time.

Abstract: Provided is a medical implant including: an implant base having a surface made of a silicon material; a linker having one end attached onto the surface of the implant base; and a cytokine bound to another end of the linker. By inducing the secretion of anti-inflammatory cytokines, a capsular contracture, which is one of the complications that may occur after transplantation of the patient's breast implant, may occur less.

Abstract: The present invention relates to a novel Usnic acid derivative exhibiting an inhibitory effect on TSLP secretion or pharmaceutically acceptable salts thereof, and a use thereof.

Abstract: Disclosed are a composition for surface modification of a medical implant and a medical implant surface-modified thereby, and according to a medical implant according to one embodiment, itaconic acid may be bound to the surface of the medical implant with high binding stability, and fibrosis inhibition and inflammatory response inhibition effects at an implantation site are exhibited.

Abstract: The present invention relates to a breast prosthesis allowing controlled release of a drug and to a production method for same, and more specifically, relates to a breast prosthesis allowing controlled release of a drug by the coupling of a drug layer comprising particles carrying the drug on the breast prosthesis, and to a production method for same.

Abstract: This invention relates to a suture including a drug-loaded polymer layer and a method of manufacturing the same, and more particularly, to a suture, the surface of which is wound with a film including a drug-loaded biodegradable polymer layer, or coated with a drug-loaded biodegradable polymer layer, and to a method of manufacturing the same.

Abstract: The present invention relates to a breast prosthesis allowing controlled release of a drug and to a production method for same, and more specifically, relates to a breast prosthesis allowing controlled release of a drug by the coupling of a drug layer comprising particles carrying the drug on the breast prosthesis, and to a production method for same.

Abstract: Disclosed is a formulation for coating a medical device which comprises an anti-scarring agent and a biocompatible polymer for regulating the release of the anti-scarring agent, wherein the mass ratio of the biocompatible polymer to the anti-scaring agent is from 100:15 to 100:0 in which 0 is not included. The present formulation can be advantageously used for coating medical devices for a sustained release of the agents from the device, thus effectively minimizing or preventing the formation of scar tissues resulted from the use of implantable and non-implantable medical devices.

Abstract: This invention relates to a suture including a drug-loaded polymer layer and a method of manufacturing the same, and more particularly, to a suture, the surface of which is wound with a film including a drug-loaded biodegradable polymer layer, or coated with a drug-loaded biodegradable polymer layer, and to a method of manufacturing the same.